| PDCA循环在重点监控药品管理中的应用效果 |
| |
| 引用本文： | 袁雍,邵燕飞,毛小红,叶晓兰,胡颖,石佳娜,郑小春,杨秀丽.PDCA循环在重点监控药品管理中的应用效果[J].中国现代应用药学,2019,36(12):1578-1582. |
| |
| 作者姓名： | 袁雍 邵燕飞 毛小红 叶晓兰 胡颖 石佳娜 郑小春 杨秀丽 |
| |
| 作者单位： | 浙江省立同德医院, 杭州 310012,浙江省人民医院, 杭州 310014,浙江省人民医院, 杭州 310014,浙江省人民医院, 杭州 310014,浙江省人民医院, 杭州 310014,浙江省人民医院, 杭州 310014,浙江省人民医院, 杭州 310014,浙江省人民医院, 杭州 310014 |
| |
| 摘 要： | 目的 评价计划-实施-检查-处理（PDCA）循环管理方法提高重点监控药品合理使用管控措施的效果。方法 应用PDCA循环管理方法完善重点监控药品管控制度、监测预警、点评通报、考核奖惩等措施，比较2016年7月-2017年6月（PDCA执行前）和2017年7月-2018年6月（PDCA执行后）重点监控药品管控效果。结果 执行PDCA循环管理方法前后，重点监控药品的DDDs从1 442 055.98下降至1 221 586.24，销售金额从13 916.27万元下降至12 315.75万元，使用合理率从61.53%上升至87.01%。结论 PDCA循环管理方法能改善重点监控药品管控效果。
|
| 关 键 词： | 计划-实施-检查-处理(PDCA) 重点监控药品 管控 药品费用 合理用药 |
| 收稿时间： | 2018/12/2 0:00:00 |
| 修稿时间： | 2019/6/5 0:00:00 |
Application Effects of PDCA Circulation on Management of Key Monitoring Drugs in a Hospital |
| |
| YUAN Yong,SHAO Yanfei,MAO Xiaohong,YE Xiaolan,HU Ying,SHI Jian,ZHENG Xiaochun and YANG Xiuli.Application Effects of PDCA Circulation on Management of Key Monitoring Drugs in a Hospital[J].The Chinese Journal of Modern Applied Pharmacy,2019,36(12):1578-1582. |
| |
| Authors: | YUAN Yong SHAO Yanfei MAO Xiaohong YE Xiaolan HU Ying SHI Jian ZHENG Xiaochun and YANG Xiuli |
| |
| Institution: | Tongde Hospital of Zhejiang Province, Hangzhou 310012, China,Zhejiang Provincial People''s Hospital, Hangzhou 310014, China,Zhejiang Provincial People''s Hospital, Hangzhou 310014, China,Zhejiang Provincial People''s Hospital, Hangzhou 310014, China,Zhejiang Provincial People''s Hospital, Hangzhou 310014, China,Zhejiang Provincial People''s Hospital, Hangzhou 310014, China,Zhejiang Provincial People''s Hospital, Hangzhou 310014, China and Zhejiang Provincial People''s Hospital, Hangzhou 310014, China |
| |
| Abstract: | OBJECTIVE To evaluate the effect of plan-do-check-act(PDCA) cycle management method on improving key monitoring drugs control measures. METHODS PDCA cycle management method was applied to improve key monitoring drugs control system, early warning, reward and punishment system as well, control efficacy of key monitoring drugs between July 2016-June 2017(before PDCA implementation) and July 2017-June 2018(after PDCA implementation) was compared. RESULTS After implementation of PDCA cycle management, the DDDs of key monitoring drugs fell from 1 442 055.98 to 1 221 586.24, the sales amount fell from 139 162 725.28 yuan to 123 157 464.54 yuan, the reasonable use rate increased from 61.53% to 87.01%. CONCLUSION Application of PDCA cycle can improve control efficacy of key monitoring drugs. |
| |
| Keywords: | plan-do-check-act(PDCA) key monitoring drugs management and control drug expense rational use |
|
| 点击此处可从《中国现代应用药学》浏览原始摘要信息 |
| 点击此处可从《中国现代应用药学》下载免费的PDF全文 |
|
